Paul M. Ness
Direktor/Vorstandsmitglied bei Hemanext, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Andrew Dunham | M | - |
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | - |
| Adam Kaplin | M | 57 |
The Johns Hopkins University
| 26 Jahre |
| Martin A. Cannon | M | - |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | 20 Jahre |
| Ismail Kola | M | 67 |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | 2 Jahre |
| Ming Zhao Xing | M | 62 |
The Johns Hopkins University
| 13 Jahre |
| William Patrick O'Neill | M | - |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | - |
| Chirag Parikh | M | 51 |
The Johns Hopkins University
| 6 Jahre |
| Steve Eckert | M | - |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | - |
| Guy Cogan | M | - |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | - |
| Eduardo Miguel Avayú Guiloff | M | - |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | - |
| Mario Eisenberger | M | 75 |
The Johns Hopkins University
| 31 Jahre |
| Redonda Miller | M | 57 |
The Johns Hopkins University
| 18 Jahre |
| Kenneth J. Pienta | M | 64 |
The Johns Hopkins University
| 30 Jahre |
| Paul A. Bottomley | M | 70 |
The Johns Hopkins University
| 30 Jahre |
| John Ruffle | M | 87 |
The Johns Hopkins University
| 34 Jahre |
| Edward G. Amoroso | M | - |
The Johns Hopkins University
| 8 Jahre |
| Frank Fabozzi | M | 76 |
The Johns Hopkins University
| 3 Jahre |
| Jerry L. Prince | M | - |
The Johns Hopkins University
| 26 Jahre |
| Edward Zyszkowski | M | - |
The Johns Hopkins University
| 15 Jahre |
| Bahija Jallal | M | 62 |
The Johns Hopkins University
| 10 Jahre |
| Paul Rothman | M | 65 |
The Johns Hopkins University
| 12 Jahre |
| Daniel Francis Hanley | M | 72 |
The Johns Hopkins University
| 28 Jahre |
| Otis Brawley | M | 64 |
The Johns Hopkins University
| 5 Jahre |
| William C. Richardson | M | 82 |
The Johns Hopkins University
| 34 Jahre |
| Michael David Testa | M | - |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | - |
| David Sidransky | M | 64 |
The Johns Hopkins University
| 26 Jahre |
| Ronald Daniels | M | 64 |
The Johns Hopkins University
| 15 Jahre |
| Richard Perle | M | 81 |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | - |
| Matthias Stuber | M | - |
The Johns Hopkins University
| 22 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sami Alom | M | 44 |
The Johns Hopkins University
| 13 Jahre |
| Jack J. Kogut | M | 77 |
Northfield Laboratories, Inc.
 Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | 15 Jahre |
| Howard P. Offit | M | - |
The Johns Hopkins University
| 10 Jahre |
| Francisco Tejada | M | - |
The Johns Hopkins University
| 9 Jahre |
| Steven A. Gould | M | 77 |
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | 16 Jahre |
| Nasif Mohammed | M | - |
The Johns Hopkins University
| 5 Jahre |
| Ari Charles Abramson | M | - |
The Johns Hopkins University
| 2 Jahre |
| Matthew R. Johnson | M | - |
The Johns Hopkins University
| 6 Jahre |
| John Chung | M | - |
The Johns Hopkins University
| 4 Jahre |
| Saliq Jamil Khan | M | - |
The Johns Hopkins University
| 3 Jahre |
| Larry Zeitlin | M | - |
The Johns Hopkins University
| 9 Jahre |
| Omar Shaher Itum | M | - |
The Johns Hopkins University
| 5 Jahre |
| Philip James Aiken | M | - |
The Johns Hopkins University
| 4 Jahre |
| Erik von Heijne | M | 34 |
The Johns Hopkins University
| 5 Jahre |
| Patrik Johansson | M | - |
The Johns Hopkins University
| 4 Jahre |
| Julianto Sidarto | M | - |
The Johns Hopkins University
| 5 Jahre |
| Greco Song | M | - |
The Johns Hopkins University
| 5 Jahre |
| Gabriel Denis | M | - |
The Johns Hopkins University
| 4 Jahre |
| Thomas Conrad | M | - |
The Johns Hopkins University
| 6 Jahre |
| Sam Yilmaz | M | - |
The Johns Hopkins University
| 7 Jahre |
| Jayden Kunwar | M | - |
The Johns Hopkins University
| 5 Jahre |
| Vishnu Joshi | M | - |
The Johns Hopkins University
| 5 Jahre |
| Shreya Singh | F | - |
The Johns Hopkins University
| 5 Jahre |
| Jordan Pryor | M | - |
The Johns Hopkins University
| 5 Jahre |
| James Gettinger | M | - |
The Johns Hopkins University
| 4 Jahre |
| Jan Martin Witte | M | 50 |
The Johns Hopkins University
| 6 Jahre |
| Dennis Deng | M | - |
The Johns Hopkins University
| 5 Jahre |
| David Glass | M | - |
The Johns Hopkins University
| 5 Jahre |
| Arman Koul | M | - |
The Johns Hopkins University
| 4 Jahre |
| Macauley Kilbane | M | - |
The Johns Hopkins University
| 5 Jahre |
| Nikhil Panu | M | - |
The Johns Hopkins University
| 4 Jahre |
| Charles D. Miller | M | 96 |
The Johns Hopkins University
| - |
| Weina Shi | F | - |
The Johns Hopkins University
| 5 Jahre |
| Bryan D. Jarman | M | - |
The Johns Hopkins University
| 5 Jahre |
| Nabil Lawandy | M | - |
The Johns Hopkins University
| 3 Jahre |
| Dale Ellen Lupu | M | - |
The Johns Hopkins University
| 5 Jahre |
| George A. Hides | M | 57 |
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | 14 Jahre |
| Shahab Vagefi | M | - |
The Johns Hopkins University
| 5 Jahre |
| Tri Luu Pham | M | 58 |
The Johns Hopkins University
| 5 Jahre |
| Ajay Mantha | M | - |
The Johns Hopkins University
| 4 Jahre |
| Jeff Raider | M | 43 |
The Johns Hopkins University
| 5 Jahre |
| John J. Hinds | M | - |
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | - |
| Michael Strine | M | - |
The Johns Hopkins University
| - |
| Peter Donnelly | M | - |
The Johns Hopkins University
| 3 Jahre |
| Gunther Birznieks | M | 55 |
The Johns Hopkins University
| 6 Jahre |
| Anne Milne | F | - |
The Johns Hopkins University
| 1 Jahre |
| Mary Miller | F | 68 |
The Johns Hopkins University
| - |
| John Watkins | M | - |
The Johns Hopkins University
| 5 Jahre |
| Rick Bernstein | M | - |
The Johns Hopkins University
| 8 Jahre |
| Bahaa W. Fam | M | - |
The Johns Hopkins University
| 5 Jahre |
| Mark Thomas Kelly | M | - |
The Johns Hopkins University
| 6 Jahre |
| Edward cho | M | - |
The Johns Hopkins University
| 6 Jahre |
| Tamitha W. McKinnis | M | - |
The Johns Hopkins University
| 7 Jahre |
| Jessica Zeaske | M | - |
The Johns Hopkins University
| 4 Jahre |
| Lou Forster | M | 64 |
The Johns Hopkins University
| 5 Jahre |
| James A. Tzitzouris | M | 50 |
The Johns Hopkins University
| 6 Jahre |
| Nikhil S. Palekar | M | - |
The Johns Hopkins University
| 5 Jahre |
| Lucy Webster | F | - |
The Johns Hopkins University
| 6 Jahre |
| Sean P. McWilliams | M | - |
The Johns Hopkins University
| 9 Jahre |
| Brandon W. Chan | M | - |
The Johns Hopkins University
| 8 Jahre |
| Sunil Yadav | M | 54 |
The Johns Hopkins University
| 5 Jahre |
| John Glover | M | - |
The Johns Hopkins University
| 2 Jahre |
| Ronald Black | M | - |
The Johns Hopkins University
| 4 Jahre |
| Andrew Evans | M | - |
The Johns Hopkins University
| 1 Jahre |
| Alexander Demyanets | M | - |
The Johns Hopkins University
| 3 Jahre |
| Kurt Edward Reiman | M | - |
The Johns Hopkins University
| 1 Jahre |
| George Huang | M | - |
The Johns Hopkins University
| 3 Jahre |
| Peter Sherwood | M | - |
The Johns Hopkins University
| 1 Jahre |
| Russell Shaller | M | 60 |
The Johns Hopkins University
| 2 Jahre |
| Naji Khoury | M | - |
The Johns Hopkins University
| 1 Jahre |
| Kayoko Lyons | F | - |
The Johns Hopkins University
| 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Paul M. Ness
- Persönliches Netzwerk
